Infrastructure investor International Public Partnerships reaffirmed that its investment portfolio had continued to perform well, with no material changes to performance since its interim results...
Pharmaceutical giant AstraZeneca its antibody imfinzi had been approved in the US for an additional dosing option to treat non-small cell lung cancer after chemoradiation...